Skip to main content
  • Home
  • COVID-19
  • Issues
    • Current Issue
    • All Issues
    • Online First
    • Supplement
    • CME
  • About
  • For Authors
    • Instructions for Authors
    • Submission Fee
    • Submit Manuscript
  • Podcasts

Patients with low levels of high-density lipoprotein cholesterol: to treat or not to treat?

< Back to Listing

Share this Article

Singapore Med J 2005; 46(10): 519-528
Patients with low levels of high-density lipoprotein cholesterol: to treat or not to treat?

  • Abstract
  • PDF

S Tavintharan, SC Lim, CF Sum
Correspondence: Dr S Tavintharan, tavintharan_subramaniam@alexhosp.com.sg

ABSTRACT
Clinical evidence indicates that a low level of high-density lipoprotein cholesterol (HDL-C) is a major risk of atherosclerosis. Raising HDL-C reduces this risk significantly, making HDL-C levels an important target of treatment for dyslipidaemia, especially in pre-existent atherosclerosis. HDL-C is protective against atherosclerosis, largely due to its function of reverse cholesterol transport. Additionally, some important roles include fibrinolysis, antioxidant functions, and reduction of platelet aggregability. A number of agents potentially modify HDL favourably. Niacin is the most potent HDL-C raising agent currently available in clinical practice, followed by fibrates. CETP inhibitors show greater HDL-C rising, but are still used in trial settings only. HDL mimetic agents are another group of agents that offer much promise. Clinical outcome data are awaited for these newer therapeutic agents.

Keywords: apolipoprotein A-l, atherosclerosis, high-density lipoprotein, hypoalphalipoproteinaemia
Singapore Med J 2005; 46(10): 519-528

http://smj.org.sg/sites/default/files/4610/4610ra1.pdf
×
POPULAR THIS MONTH
Managing unhealthy alcohol use in general practice
Controversies and discrepancies in the effect of dietary fat and cholesterol on cardiovascular risk
Clinics in diagnostic imaging (209)
A retrospective review of trampoline-related injuries presenting to a paediatric emergency department in Singapore

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.